Eagle Health Investments’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-174,902
Closed -$35.4M 32
2023
Q1
$35.4M Hold
174,902
6.89% 5
2022
Q4
$22.5M Hold
174,902
5.19% 13
2022
Q3
$23.9M Sell
174,902
-87,600
-33% -$14.3M 5.49% 8
2022
Q2
$46.4M Buy
262,502
+32,000
+14% +$4.61M 10.83% 1
2022
Q1
$33.2M Buy
230,502
+150,002
+186% +$20.3M 8.18% 2
2021
Q4
$12.4M Buy
+80,500
New +$13.5M 3.03% 18

Other funds holding SGEN

Eagle Health Investments's SGEN Position: Q2 2023 in Review

Eagle Health Investments sold out of Seagen Inc. Common Stock (SGEN) in Q2 2023, closing a stake of 174,902 shares — an estimated $35.4M sold.

Eagle Health Investments first reported a position in SGEN in Q4 2021 and held it in 6 quarters. The position peaked at $46.4M in Q2 2022. 596 funds tracked by Wall St. Rank hold SGEN as of Q2 2023.

  • Eagle Health Investments reported no remaining Seagen Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Eagle Health Investments sold 174,902 Seagen Inc. Common Stock shares in Q2 2023, an estimated $35.4M.
  • Eagle Health Investments first reported a position in Seagen Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Eagle Health Investments's Seagen Inc. Common Stock position peaked at $46.4M in Q2 2022.
  • 596 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2023.

Based on Eagle Health Investments's 13F filing for Q2 2023, filed 14 Aug 2023.